Wilsons disease is a rare genetic disorder that affects the body's ability to metabolize copper. It is estimated to occur in approximately 1 in every 30,000 to 40,000 individuals worldwide. The prevalence of Wilsons disease varies among different populations, with higher rates reported in certain regions such as Eastern Europe and Asia. If left untreated, Wilsons disease can lead to serious complications affecting the liver, brain, and other organs. Early diagnosis and treatment are crucial for managing the condition and preventing long-term damage.
Wilsons disease is a rare genetic disorder that affects the body's ability to metabolize copper, leading to its accumulation in various organs, particularly the liver and brain. It is estimated to occur in approximately 1 in 30,000 to 1 in 100,000 individuals worldwide, making it relatively uncommon.
The prevalence of Wilsons disease varies among different populations. It is more commonly found in individuals of Eastern European, Mediterranean, and Asian descent. In these populations, the prevalence can be as high as 1 in 5,000 individuals. However, it is less common in other ethnic groups.
Wilsons disease typically manifests between the ages of 5 and 35, with symptoms ranging from liver dysfunction to neurological and psychiatric disturbances. If left untreated, it can lead to severe complications and even death. Early diagnosis and treatment are crucial for managing the disease and preventing long-term damage.
Given its rarity, Wilsons disease may often go undiagnosed or misdiagnosed, making awareness and screening important for early detection. Genetic testing and liver function tests are commonly used to diagnose the condition.